// App-Quantinova.ai

P591 : Therapeutic drug monitoring in Paediatric inflammatory bowel disease on maintenance infliximab and adalimumab treatment improves clinical remission with a proactive approach

Researchers

Presenter

  • S. Chadokufa

Principal Investigators

  • S. Sider

  • B. Huggett

  • T. Sawney

  • N. Shah

  • M. Baycheva

  • A. Zambrano Perez

  • N. Acton

  • F. Kiparissi

Medical Centers

  • Great Ormond Street Hospital, Paediatric Gastroenterology, London, United Kingdom

  • University College London Hospitals NHS Foundation Trust, Department of Colorectal Surgery, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

  • Human albumin

  • Tumor necrosis factor

Drug/Treatment

  • Entyvio

  • Adalimumab

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved